A phase II trial of uracil ointment for the prevention of capecitabine induced hand-foot syndrome (HFS):

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2014
INTERVENTION: Uracil ointment application to the palmar and plantar skin. CONDITION: Advanced or recurrent breast cancer PRIMARY OUTCOME: Incidence and appearance time of Grade 2 HFS. INCLUSION CRITERIA: Histologically confirmed advanced or recurrent breast cancer.
Epistemonikos ID: a00fe282a44030ef6b97ad0a3fc71c37a6581cd3
First added on: Aug 23, 2024